Extracellular matrix glycosaminoglycan network (ECM GAG network)

The extracellular matrix (ECM) glycosaminoglycan (GAG) network is a complex, highly hydrated scaffold of anionic polysaccharides, including hyaluronan, heparan sulfate, and chondroitin sulfate, that fills the interstitial space between cells (Frantz et al., 2010, J Cell Sci). These molecules are critical for maintaining tissue structural integrity and regulating the bioavailability of growth factors and cytokines through specific binding interactions (Morla, 2019, Int J Mol Sci). In pathological conditions such as cancer and fibrosis, the GAG network undergoes significant remodeling, characterized by increased deposition or altered sulfation patterns that promote tumor invasion and immune evasion (Schultheis et al., 2019, Front Oncol). Pharmacological targeting of this network involves diverse strategies, such as the use of hyaluronidase enzymes to degrade hyaluronan and improve the penetration of co-administered chemotherapeutics (NCBI, StatPearls). Additionally, heparin-based drugs exploit the anticoagulant properties of heparan sulfate mimetics to modulate blood clotting (PubChem). Because the GAG network is ubiquitous, therapeutic interventions must carefully balance the disruption of pathological matrices with the preservation of essential physiological functions in healthy tissues.

Other names

ECM GAGsExtracellular glycosaminoglycansProteoglycan-GAG complexGround substanceInterstitial glycosaminoglycan network

Enzymatic degradation of glycosaminoglycan chains, competitive inhibition of GAG-protein interactions, and enzyme replacement therapy for GAG catabolism.